🦊/Investors

Eos Advisory β€” Full Portfolio

24 tracked investments Β· listed companies and verified rows first

Dxcoverdxcover.comin𝕏Feb 2025 Β· $6.2Mβœ“ verified

Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsScottish EnterpriseAlba EquityBritish Business BankMaven Capital Partners

TaiSantaisan.co.ukinJul 2026βœ“ verified

TaiSan develops sodium batteries and works with operators, OEMs and research institutions to deploy them into vehicle fleets.

Advanced ManufacturingCleantechEnergyHardwareNew Materials

Co-investorsAdelineEIT InnoEnergyAFI VenturesMercia VenturesTSP VenturesHeartfelt Capital+1 more

Bioliberty.Cobioliberty.co.ukin

Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to more patients.

Digital HealthMedical DevicesRobotics

Biotangents.Cobiotangents.co.uk

Biotangents develops AmpliSpec, a LAMP-based molecular diagnostics platform for veterinary use that delivers pathogen-specific results in under two hours at the point of care, in laboratories, or embedded within partner systems.

AgTechBiotechMedical Devices

CamGene Therapeuticscamgenetx.comin

CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss.

BiotechDeep TechHealthtechCambridge, GB

Arpan Desai(CEO & Co-founder)inPrashant Shah(Co-founder)Sunil Shah(Co-founder)

Co-investorsCambridge Angels groupFuture Planet CapitalUK Innovation & Science Seed Fund

Carcinotechcarcinotech.cominJan 2024

Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB

Lorna(Chief Scientific Officer)

Co-investorsAlba EquityTRICAPITALBritish Business BankGabriel Investment SyndicateInvesting Women AngelsMaven Capital+3 more

Carcinotech.Cocarcinotech.co.ukinDec 2023

Carcinotech develops tumor models and assay solutions to improve preclinical drug development for cancer therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesScotland, GB

Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)Lorna(Chief Scientific Officer)Susanne

Chemifychemify.ioin

Chemify builds automated chemical synthesis systems combining chemistry, AI, and robotics to digitize molecular design and manufacturing.

AI & Machine LearningBiotechDeep TechGlasgow, GB

Lee Cronin(Founder)in

Co-investorsBlueYard CapitalInsight PartnersHAWKTAILHorizons VenturesLauder PartnersRocketship.vc+3 more

Concinnitytheconcinnitycompany.cominDec 2024

The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials.

Cloud ComputingDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNashville, US

Heidi Solomon Allen(Secretary)inMichael Alan Lalor(Chief Financial Officer)Nancy Falls(Chief Executive Officer)in

Co-investorsMaven Capital PartnersOld College CapitalScottish Enterprise

Concinnitygeneticsconcinnitygenetics.comin

Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies.

AI & Machine LearningBiotechHealthtechEdinburgh, GB

Jessica Birt(Co-founder & CEO)inMatthew Dale(Co-founder & CSO)in

Cumulus Oncologycumulusoncology.cominJan 2024 Β· $5.6M

Cumulus Oncology is a drug development company specializing in oncology therapeutics, leveraging experienced leadership with track records in new drug applications and successful M&A transactions.

BiotechHealthtechLongevityMedical Devices

Catherine(CEO)Clare Wareing(CEO)in

Co-investorsAlba EquityApollo Informal InvestmentScottish National Investment BankScottish Enterprise

Enough Foodenough-food.comin

ENOUGH produces sustainable food ingredients and works with customers, suppliers, and partners toward its mission.

FoodTechImpact & Social Good

Co-investorsDCVC (Data Collective)

Ensilitechensilitech.comin

EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration.

BiotechCleantechDeep TechHealthtechMedical Devices

Asel Sartbaeva(Co-Founder & CEO)inMatt Slade(Co-Founder & Chief of Staff)inStephen Wells(Co-Founder & Advisor)Aswin Doekhie(Co-Founder & CTO)inSabine Ficek(CFO)inSimon Bennett(Chief Commercial Officer)

Co-investorsCalculus Capital Ltd.Elbow Beach Capital

Gmflow.Cogmflow.co.ukin

GM Flow provides flow measurement solutions for oil and gas operations.

CleantechEnergyHardwareIoTAberdeen, GB

GavinVictorChrisIqbal

ILC Therapeutics Ltdilctherapeutics.comin

ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform.

BiotechDeep TechHealthtechMedical Devices

Owain Millington(CEO)in

Co-investorsMedical Incubator Japan K.K.

Laverock Therapeutics Seedlaverocktx.comin

Laverock Tx is a biotechnology company working in the gene therapy and gene editing space, with a leadership and advisory team drawn from cell and gene therapy, immunology, and life-science investing backgrounds.

BiotechDeep TechHealthtech

Co-investorsCalculus Capital Ltd.Future Planet CapitalTekfen VenturesUK Innovation & Science Seed Fund

Nami Surgicalnamisurgical.cominApr 2024 Β· $4M

Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.

HealthtechMedical DevicesRoboticsGlasgow, GB

Nico Fenu(Co-Founder & Chief Operating Officer)inREBECCA CLEARY(Executive Officer, Director)inNICOLA GIUSEPPE FENU(Executive Officer, Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)inNikki Palfrey(Chief Executive Officer)inALBERT NICHOLL(Director)in

Co-investorsMaven Capital PartnersScottish Enterprise

Naturbeadsnaturbeads.comin𝕏

Naturbeads develops biodegradable cellulose microspheres to replace microplastics in consumer products such as cosmetics and paints.

Circular EconomyCleantechNew MaterialsItaly, IT

Janet Scott(Co-founder)Davide Mattia(Co-founder)inGiovanna Laudisio(Co-founder)in

Co-investorsInnovate UKCDP Venture CapitalRegeneration.VC

Neupulseneupulse.coFeb 2026

Neupulse develops a wearable device that delivers drug-free, non-invasive neurostimulation to support everyday wellbeing and relaxation, based on neuroscience research.

HardwareHealthtechWellness & Fitness

Co-investorsMercia VenturesMidlands Engine Investment Fund II

Novosoundnovosound.netin

SenseBP is a wearable blood pressure monitoring device that eliminates the need for traditional pressure cuffs.

HardwareHealthtech

Co-investorsKelvin CapitalForesightGabriel Investments

Silverbactechsilverbactech.com

SILVERbac is a patented antimicrobial textile technology that permanently incorporates pure silver particles into fibres, making the treatment non-leaching, non-toxic, and eco-friendly.

Advanced ManufacturingCleantechHealthtechNew MaterialsDubai, GB

Wobble Genomicswobblegenomics.cominDec 2023

Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.

BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh

Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)

Co-investorsIQ CapitalMercia VenturesOld College Capital

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

Novel TechnologiesPenrhosbio

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.